Evidence map›Paper›PMID 22882361›Full record

ArticleBrain pathology (Zurich, Switzerland)2013

Characterization of thorn-shaped astrocytes in white matter of temporal lobe in Alzheimer's disease brains.

Irene López-González, Margarita Carmona, Rosa Blanco, José Luna-Muñoz, Alejandra Martínez-Mandonado, Raúl Mena, Isidre Ferrer

Open access · greenAbstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Relevance of host tau in tau seeding and spreading in tauopathies.Brain pathology (Zurich, Switzerland) · 2020
    Article
  10. Article
  11. Sisyphus in Neverland.Journal of Alzheimer's disease : JAD · 2018
    Article
  12. Deciphering the Astrocyte Reaction in Alzheimer's Disease.Frontiers in aging neuroscience · 2018
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. The neuropathology of sport.Acta neuropathologica · 2014
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Irene López-GonzálezCIBERNED (Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas), Institut de Neuropatologia, IDIBELL-Hospital Universitari de Bellvitge, Universitat de Barcelona, Hospitalet de Llobregat, Spain.
Margarita Carmona
Rosa Blanco
José Luna-Muñoz
Alejandra Martínez-Mandonado
Raúl Mena
Isidre Ferrer
Center for Research and Advanced Studies of the National Polytechnic Institute · MXInstitut d'Investigació Biomédica de Bellvitge · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thorn-shaped astrocytes (TsA) are mainly localized in the periventricular white matter of the temporal lobe in a subgroup of aged individuals usually in the context of Alzheimer's disease (AD). Immunohistochemistry of TsA shows 4Rtau deposition, tau phosphorylation at different sites recognized with phosphospecific anti-tau antibodies Thr181, Ser202, Ser214, Thr231, Ser396, Ser422, and clones AT8 and PHF-1, and conformational changes revealed with Alz50 and MC-1 antibodies; TsA are also immunostained with antibodies to active tau kinases MAPK/ERK-P, SAPK/JNK-P, p38-P and GSK-3β. These findings are common to neurofibrillary tangles in AD. However, TsA are not stained with 3Rtau antibodies, and they are seldom stained or not at all with phosphospecific tauSer262 and with Tau-C3 antibody, which recognizes the latter tau truncation at aspartic acid 421. Previous studies have shown that tau phosphorylation at Ser262 reduces tau binding to microtubules and increases caspase-3 activity, whereas tau truncation at aspartic acid 421 is associated with tau ubiquitination, and toxic effects of tau. In this line, ubiquitin is not accumulated in TsA, and in situ end-labeling of nuclear DNA fragmentation shows absence of degeneration in TsA. These observations support the concept that tau lesions in neurons differ from those seen in TsA in AD.

Indexed as

Cell ShapeAgedAged, 80 and overAlzheimer DiseaseAstrocytesAxonsCaspase 3FemaleGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansMaleMitogen-Activated Protein Kinase 8Nerve Fibers, MyelinatedNeurofibrillary TanglesNeuronsCaspase 3Glycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGSK3B protein, humanMitogen-Activated Protein Kinase 8tau Proteins

Identifiers

PMID22882361
PMCPMC8028879
OpenAlexW2117283190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.